Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kendra Sweet

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|March 28, 2024
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and OutcomesLuis E Aguirre, Akriti Jain, Somedeb Ball, et al.
Annals of Hematology|April 18, 2024
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CMLAkriti G Jain, Quinto Gesiotto, Somedeb Ball, et al.
Blood Neoplasia|October 2, 2025
A comparative assessment of molecular-based prognostic models in CMMLLuis E Aguirre, Najla Al Ali, Somedeb Ball, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2012
Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparisonKristin M Phillips, Javier Pinilla-Ibarz, Eduardo Sotomayor, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 14, 2019
Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting CellsBishwas Shrestha, Yongliang Zhang, Bin Yu, et al.
Haematologica|February 1, 2024
Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemiaAkriti G Jain, Somedeb Ball, Luis Aguirre, et al.
Leukemia|May 5, 2023
Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromesLuis E Aguirre, Najla Al Ali, David A Sallman, et al.
Blood Neoplasia|June 2, 2025
Clinical correlation and prognostic impact of cytogenetic clone size for myelodysplastic syndromes/neoplasmZhuoer Xie, Najla Al Ali, Ling Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 22, 2023
Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and OutcomesSara M Tinsley-Vance, Najla Al Ali, Somedeb Ball, et al.
Leukemia Research|May 15, 2020
Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancyChetasi Talati, Aaron D Goldberg, Amanda Przespolewski, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Clinical Lymphoma, Myeloma & Leukemia|March 28, 2024
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and OutcomesLuis E Aguirre, Akriti Jain, Somedeb Ball, et al.
Annals of Hematology|April 18, 2024
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CMLAkriti G Jain, Quinto Gesiotto, Somedeb Ball, et al.
Blood Neoplasia|October 2, 2025
A comparative assessment of molecular-based prognostic models in CMMLLuis E Aguirre, Najla Al Ali, Somedeb Ball, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2012
Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparisonKristin M Phillips, Javier Pinilla-Ibarz, Eduardo Sotomayor, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 14, 2019
Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting CellsBishwas Shrestha, Yongliang Zhang, Bin Yu, et al.
Haematologica|February 1, 2024
Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemiaAkriti G Jain, Somedeb Ball, Luis Aguirre, et al.
Leukemia|May 5, 2023
Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromesLuis E Aguirre, Najla Al Ali, David A Sallman, et al.
Blood Neoplasia|June 2, 2025
Clinical correlation and prognostic impact of cytogenetic clone size for myelodysplastic syndromes/neoplasmZhuoer Xie, Najla Al Ali, Ling Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 22, 2023
Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and OutcomesSara M Tinsley-Vance, Najla Al Ali, Somedeb Ball, et al.
Leukemia Research|May 15, 2020
Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancyChetasi Talati, Aaron D Goldberg, Amanda Przespolewski, et al.
Pageof 9